Quality of Care

  • Short-stay residents are those who spent 100 days or less in a nursing home or residents covered under the Medicare Part A Skilled Nursing Facility benefit
  • Long-stay residents are those who spent over 100 days in a nursing home
Measure Nursing Home Massachusetts Nationwide
Short-stay residents who self-report moderate to severe pain 21.2% 13.1% 12.8%
Short-stay residents with pressure ulcers that are new or worsened 0.7% 0.7% 0.9%
Short-stay residents who were assessed and appropriately given the seasonal influenza vaccine 91.3% 81.9% 81.8%
Short-stay residents assessed and appropriately given the pneumococcal vaccine 93.1% 80.1% 83.3%
Short-stay residents who newly received an antipsychotic medication 0.6% 1.6% 1.9%
Short-stay residents who made improvements in function 67.7% 62.2% 68.0%
Long-stay residents whose need for help with daily activities has increased n/a 15.0% 14.9%
Long-stay residents who self-report moderate to severe pain n/a 4.4% 5.7%
High risk long-stay residents with pressure ulcers n/a 4.4% 5.6%
Long-stay residents who lose too much weight n/a 5.8% 7.0%
Low risk long-stay residents who lose control of their bowels or bladder n/a 55.5% 48.2%
Long-stay residents with a catheter inserted and left in their bladder n/a 1.5% 1.8%
Long-stay residents with a urinary tract infection n/a 3.0% 3.0%
Long-stay residents who have depressive symptoms n/a 2.0% 4.6%
Long-stay residents who were physically restrained n/a 0.5% 0.3%
Long-stay residents experiencing one or more falls with major injury n/a 3.3% 3.4%
Long-stay residents assessed and appropriately given the seasonal influenza vaccine n/a 95.2% 95.2%
Long-stay residents assessed and appropriately given the pneumococcal vaccine n/a 91.9% 93.9%
Long-stay residents who received an antipsychotic medication n/a 17.9% 15.0%
Long-stay residents whose ability to move independently worsened n/a 17.9% 18.2%
Long-stay residents who received an antianxiety or hypnotic medication n/a 19.7% 21.6%

View details for
D'YOUVILLE CENTER FOR ADVANCE THERAPY